Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers [Phase 1, Phase 2]
The document describes an ongoing Phase 1/2 trial evaluating tivozanib for biliary tract cancers and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study for AZD4360 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 clinical trial of AZD4360 in adults with advanced solid tumors, including gastric cancer and gastroesophageal junction cancer, is …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients
AstraZeneca is conducting a multicenter, non-interventional study in Chinese pan-tumor patients to assess concordance of HER2 IHC testing ac…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients
A completed clinical study from AstraZeneca evaluating the relationship between biliary complications and treatment duration in unresectable…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer [Phase 2]
A Phase 2 study evaluating novel immunomodulators as both monotherapy and in combination with anticancer agents for advanced hepatobiliary c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating HX009 plus IN10018 with or without standard chemotherapy for advanced solid tumors, including biliary tr…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors [Phase 1]
An ongoing Phase 1 trial is evaluating BL-M05D1 in patients with solid tumors, assessing safety, tolerability, pharmacokinetics, and prelimi…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer [Phase 3]
Phase 3 trial update for D07001 softgel-capsules in combination with capecitabine in advanced biliary tract cancer; the study is not yet rec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) [Phase 2]
Phase 2 clinical trial evaluating chemotherapy with or without binimetinib for advanced biliary tract cancers. The study is currently active…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy [Phase 1]
This Phase 1 trial update describes evaluating ropidoxuridine as a radiosensitizer in patients with advanced gastrointestinal cancers underg…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors [Phase 2]
A Phase 2 clinical trial update for trastuzumab deruxtecan (Enhertu) in HER2-expressing tumors, including bladder, biliary tract, cervical, …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer [Phase 3]
This clinical trial update describes a Phase 3 study comparing Nanvuranlat to physician's best choice in adults with biliary tract cancer; r…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer [NA]
A clinical trial evaluating hepatic arterial infusion chemotherapy plus systemic therapy as a de-escalation strategy for biliary tract cance…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating TQB2102 for injection is underway for HER2-positive biliary tract cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A COMPREHENSIVE BIOMARKER EVALUATION IN BILIARY TRACT CANCER
A comprehensive biomarker evaluation study in biliary tract cancer sponsored by MedSIR is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of ZM008, an anti-LLT1 antibody, given as a single agent and then in combination with toripalimab in patients with ad…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC [Phase 2]
Phase 2 study of RP2 in combination with second-line therapy for locally advanced or metastatic hepatocellular carcinoma and biliary tract c…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy [Phase 2]
A Phase 2 clinical trial evaluates trastuzumab in combination with serplulimab and chemotherapy for HER2-overexpressing unresectable locally…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103) [Phase 1]
This is a Phase 1 trial evaluating Anvumetostat in combination with other therapies for advanced gastrointestinal, biliary tract, or pancrea…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating MP0317 in combination with chemoimmunotherapy as first-line treatment for advanced biliary tract carcino…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers [Phase 2]
A multicenter Phase 2 clinical trial evaluating Envafolimab for biliary tract cancers is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC) [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating CDX-1140, a CD40 agonist, in combination with capecitabine, oxaliplatin (CAPOX), and pembrolizum…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies [Phase 1, Phase 2]
AZD8205 is being studied in a Phase I/IIa trial as a single agent or in combination for advanced/metastatic solid tumors. Recruitment is ong…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating Adebrelimab in combination with gemcitabine, cisplatin, and simvastatin for advanced biliary tract …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors [Phase 1]
Open-label Phase 1 study evaluating BL-M07D1 in HER2-expressing malignant solid tumors, with recruitment across several tumor types includin…